drugset / Trial / NCT04630860
A Study to Evaluate the Pharmacokinetics and Safety of LY03003 in Patients With Advanced-stage PD
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study is to evaluate the pharmacokinetics and safety of LY03003 in patients with advanced-stage PD.
Timeline
- Start
- 2020-07-07
- Primary completion
- 2021-05-12
- Completion
- 2022-01-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY03003 | Unknown | 56 mg | Intramuscular |
| Subject | LY03003 | Unknown | 84 mg | Intramuscular |
| Subject | LY03003 | Unknown | 112 mg | Intramuscular |